Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1972 Jun;35(3):385–394. doi: 10.1136/jnnp.35.3.385

Multiple sclerosis associated with defects in neuromuscular transmission

Bernard M Patten 1, Avery Hart 1, Robert Lovelace 1,1
PMCID: PMC494081  PMID: 4338448

Abstract

Three patients with multiple sclerosis characterized by exacerbations and remissions of nervous system signs and symptoms disseminated in time and space also had the kind of easy fatiguability seen in myasthenia gravis. In each case abnormal decrements to repetitive stimulation were electromyographically demonstrated and treatment with ephedrine or anticholinesterase drugs increased the patient's functional capacity while improving the electromyographic abnormality. The suggestion is that these patients represent an overlap syndrome, analogous to the overlap syndrome existing between systemic lupus erythematosus and rheumatoid arthritis where clinical and laboratory features of two diseases coexist in the same patient at the same time. Presumably some patients with multiple sclerosis have deficient production of acetylcholine, just like patients with myasthenia, and treatment with agents useful in myasthenia is able partially to correct the symptoms caused by the deficiency. The cases illustrate how in neurology greater attention to the more immediate cause of clinical symptoms, in the absence of a known aetiology, may result in benefit to the patients.

Full text

PDF
385

Images in this article

386Image
on p.386
387Image
on p.387
388Image
on p.388
389Image
on p.389
390Image
on p.390
391Image
on p.391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baginsky R. G. A case of peripheral polyneuropathy displaying myasthenic EMG patterns. Electroencephalogr Clin Neurophysiol. 1968 Oct;25(4):397–397. [PubMed] [Google Scholar]
  2. Beutner E. H., Chorzelski T. P., Hale W. L., Hausmanowa-Petrusewicz I. Autoimmunity in concurrent myasthenia gravis and pemphigus erythematosus. JAMA. 1968 Mar 4;203(10):845–849. [PubMed] [Google Scholar]
  3. Connor R. C. Causes of disseminated sclerosis. Lancet. 1970 Apr 4;1(7649):724–725. doi: 10.1016/s0140-6736(70)90964-5. [DOI] [PubMed] [Google Scholar]
  4. Desmedt J. E. Presynaptic mechanisms in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):209–246. doi: 10.1111/j.1749-6632.1966.tb45474.x. [DOI] [PubMed] [Google Scholar]
  5. Dowling P. C., Cook S. D. Pattern of cellular and humoral events in experimental allergic encephalomyelitis. Neurology. 1968 Oct;18(10):953–962. doi: 10.1212/wnl.18.10.953. [DOI] [PubMed] [Google Scholar]
  6. Ekbom K. Familial multiple sclerosis associated with narcolepsy. Arch Neurol. 1966 Oct;15(4):337–344. doi: 10.1001/archneur.1966.00470160003001. [DOI] [PubMed] [Google Scholar]
  7. Engel W. K., McFarlin D. E. Muscle lesions in myasthenia gravis. Discussion. Ann N Y Acad Sci. 1966 Jan 26;135(1):68–78. doi: 10.1111/j.1749-6632.1966.tb45464.x. [DOI] [PubMed] [Google Scholar]
  8. Engel W. K., Meltzer H. Histochemical abnormalities of skeletal muscle in patients with acute psychoses. Science. 1970 Apr 10;168(3928):273–276. doi: 10.1126/science.168.3928.273. [DOI] [PubMed] [Google Scholar]
  9. Grob D., Namba T. Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses. JAMA. 1966 Nov 14;198(7):703–707. [PubMed] [Google Scholar]
  10. Halperin I. C., Minogue W. F., Komninos Z. D. Autoimmune hemolytic anemia and myasthenia gravis associated with thymoma. N Engl J Med. 1966 Sep 22;275(12):663–664. doi: 10.1056/NEJM196609222751210. [DOI] [PubMed] [Google Scholar]
  11. Holmes F. F., Stubbs D. W., Larsen W. E. Systemic lupus erythematosus and multiple sclerosis in identical twins. Arch Intern Med. 1967 Mar;119(3):302–304. [PubMed] [Google Scholar]
  12. Kornguth S. E., Hanson J. C., Chun R. W. Antineuronal antibodies in patients having myasthenia gravis. Neurology. 1970 Aug;20(8):749–755. doi: 10.1212/wnl.20.8.749. [DOI] [PubMed] [Google Scholar]
  13. Lambert E. H. Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):367–384. doi: 10.1111/j.1749-6632.1966.tb45484.x. [DOI] [PubMed] [Google Scholar]
  14. Lovelace R. E., Horwitz S. J. Peripheral neuropathy in long-term diphenylhydantoin therapy. Arch Neurol. 1968 Jan;18(1):69–77. doi: 10.1001/archneur.1968.00470310083007. [DOI] [PubMed] [Google Scholar]
  15. MULDER D. W., LAMBERT E. H., EATON L. M. Myasthenic syndrome in patients with amyotrophic lateral sclerosis. Neurology. 1959 Oct;9:627–631. doi: 10.1212/wnl.9.10.627. [DOI] [PubMed] [Google Scholar]
  16. McQuillen M. P., Cantor H. E., O'Rourke J. R. Myasthenic syndrome associated with antibiotics. Arch Neurol. 1968 Apr;18(4):402–415. doi: 10.1001/archneur.1968.00470340088008. [DOI] [PubMed] [Google Scholar]
  17. Mertens H. G., Balzereit F., Leipert M. The treatment of severe myasthenia gravis with immunosuppressive agents. Eur Neurol. 1969;2(6):321–339. doi: 10.1159/000113809. [DOI] [PubMed] [Google Scholar]
  18. Namerow N. S., Thompson L. R. Plaques, symptoms, and the remitting course of multiple sclerosis. Neurology. 1969 Aug;19(8):765–774. doi: 10.1212/wnl.19.8.765. [DOI] [PubMed] [Google Scholar]
  19. Norris F. H., Jr Neuromuscular transmission in thyroid disease. Ann Intern Med. 1966 Jan;64(1):81–86. doi: 10.7326/0003-4819-64-1-81. [DOI] [PubMed] [Google Scholar]
  20. Peterson H. Association of trimethadione therapy and myasthenia gravis. N Engl J Med. 1966 Mar 3;274(9):506–507. doi: 10.1056/NEJM196603032740908. [DOI] [PubMed] [Google Scholar]
  21. Rinne U. K., Tuovinen T. Electrophysiological studies on peripheral nervous function in multiple sclerosis. Ann Med Intern Fenn. 1968;57(4):173–177. [PubMed] [Google Scholar]
  22. Roberts D. V., Wilson A. Electromyography in the diagnosis and treatment of myasthenia gravis. Br J Pharmacol. 1968 Sep;34(1):229P–230P. [PMC free article] [PubMed] [Google Scholar]
  23. Rosman N. P., Rebeiz J. J. The cerebral defect and myopathy in myotonic dystrophy. A comparative clinicopathological study. Neurology. 1967 Nov;17(11):1106–1112. doi: 10.1212/wnl.17.11.1106. [DOI] [PubMed] [Google Scholar]
  24. Schneck S. A., Claman H. N. CSF immunoglobulins in multiple sclerosis and other neurologic diseases. Measurement by electroimmunodiffusion. Arch Neurol. 1969 Feb;20(2):132–139. doi: 10.1001/archneur.1969.00480080032003. [DOI] [PubMed] [Google Scholar]
  25. Simpson J. A. Applied electrophysiology in nerve and muscle disease. Disorders of neuromuscular transmission. Proc R Soc Med. 1966 Oct;59(10):993–998. [PMC free article] [PubMed] [Google Scholar]
  26. Simpson J. A. Myasthenia gravis as an autoimmune disease: clinical aspects. Ann N Y Acad Sci. 1966 Jan 26;135(1):506–516. doi: 10.1111/j.1749-6632.1966.tb45499.x. [DOI] [PubMed] [Google Scholar]
  27. WARD P. H., CANNON D., LINDSAY J. R. THE VESTIBULAR SYSTEM IN MULTIPLE SCLEROSIS. A CLINICAL-HISTOPATHOLOGICAL STUDY. Laryngoscope. 1965 Jul;75:1031–1047. doi: 10.1288/00005537-196507000-00001. [DOI] [PubMed] [Google Scholar]
  28. WORDEN D. K., VIGNOS P. J., Jr Intellectual function in childhood progressive muscular dystrophy. Pediatrics. 1962 Jun;29:968–977. [PubMed] [Google Scholar]
  29. Watkins S. M., Espir M. Migraine and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1969 Feb;32(1):35–37. doi: 10.1136/jnnp.32.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES